Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Eriguchi

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Kidney International|June 19, 2014
Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney diseaseMasahiro Eriguchi, Kazuhiko Tsuruya, Naoki Haruyama, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 16, 2017
Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort StudyRyusuke Yotsueda, Masatomo Taniguchi, Shigeru Tanaka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 29, 2014
Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysisShunsuke Yamada, Kazuhiko Tsuruya, Masatomo Taniguchi, et al.
American Journal of Physiology. Renal Physiology|December 4, 2015
Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathiesMasahiro Eriguchi, Ryusuke Yotsueda, Kumiko Torisu, et al.
BMJ Open Diabetes Research & Care|November 5, 2020
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathySadanori Okada, Ken-Ichi Samejima, Masaru Matsui, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysisShunsuke Yamada, Kazuhiko Tsuruya, Masanori Tokumoto, et al.
Clinical and Experimental Nephrology|January 1, 2022
Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deathsShinichiro Kubo, Tatsuya Noda, Tomoya Myojin, et al.
F1000Research|March 29, 2016
Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune responseKenneth E Bernstein, Zakir Khan, Jorge F Giani, et al.
Case Reports in Nephrology and Dialysis|June 14, 2019
Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse TherapySatoshi Toyota, Masahiro Eriguchi, Shoko Hasegawa, et al.
Biochemical and Biophysical Research Communications|January 21, 2026
High expression of angiotensin-converting enzyme in macrophages exacerbates renal interstitial damage in diabetic miceTakayuki Uemura, Keigo Tomita, Masahiro Eriguchi, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Kidney International|June 19, 2014
Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney diseaseMasahiro Eriguchi, Kazuhiko Tsuruya, Naoki Haruyama, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 16, 2017
Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort StudyRyusuke Yotsueda, Masatomo Taniguchi, Shigeru Tanaka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 29, 2014
Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysisShunsuke Yamada, Kazuhiko Tsuruya, Masatomo Taniguchi, et al.
American Journal of Physiology. Renal Physiology|December 4, 2015
Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathiesMasahiro Eriguchi, Ryusuke Yotsueda, Kumiko Torisu, et al.
BMJ Open Diabetes Research & Care|November 5, 2020
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathySadanori Okada, Ken-Ichi Samejima, Masaru Matsui, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysisShunsuke Yamada, Kazuhiko Tsuruya, Masanori Tokumoto, et al.
Clinical and Experimental Nephrology|January 1, 2022
Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deathsShinichiro Kubo, Tatsuya Noda, Tomoya Myojin, et al.
F1000Research|March 29, 2016
Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune responseKenneth E Bernstein, Zakir Khan, Jorge F Giani, et al.
Case Reports in Nephrology and Dialysis|June 14, 2019
Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse TherapySatoshi Toyota, Masahiro Eriguchi, Shoko Hasegawa, et al.
Biochemical and Biophysical Research Communications|January 21, 2026
High expression of angiotensin-converting enzyme in macrophages exacerbates renal interstitial damage in diabetic miceTakayuki Uemura, Keigo Tomita, Masahiro Eriguchi, et al.
Pageof 8